Vi­iV takes to the couch for con­ver­sa­tions about HIV in its new ‘Sci­ence on the So­fa’ se­ries

3 years ago
Pharma
Marketing

CDC sur­vey re­veals Covid-19 vac­ci­na­tion rates for chil­dren re­main low

3 years ago
Pharma
Coronavirus

Leg­end CEO spells out path to $5B in sales for mul­ti­ple myelo­ma CAR-T ther­a­py Carvyk­ti

3 years ago
China
Cell/Gene Tx

Con­gress takes an­oth­er look at re­clas­si­fy­ing psilo­cy­bin and MD­MA

3 years ago
Pharma

Be­yond the IRA: Re­search points to need for even low­er co­pay caps for some Part D ben­e­fi­cia­ries

3 years ago
Pharma

Eu­ro­pean pro­tein soft­ware start­up Cra­dle launch­es with back­ing from Lyft, Twist CEOs

3 years ago
Financing
Startups

FDA hits Io­vance with one more de­lay for TIL ther­a­py, ex­tend­ing BLA fil­ing un­til 2023

3 years ago
Cell/Gene Tx
FDA+

PaxMed­ica surges af­ter fi­nanc­ing; Mar­i­nus makes Chi­na de­vel­op­ment and sales pact

3 years ago
News Briefing

Pfiz­er and BioN­Tech roll out new da­ta for their bi­va­lent boost­er against new­er Omi­cron vari­ants

3 years ago
R&D
Pharma

Up­dat­ed: Proven­tion prices drug to de­lay type I di­a­betes at $193K as FDA nod kicks off US launch with Sanofi

3 years ago
FDA+

Ex-Ru­bius CEO dusts him­self off at a dif­fer­ent Flag­ship biotech; Hutchmed switch­es things up dur­ing pipeline re­fo­cus

3 years ago
Peer Review

In­ovio drops MERS and Las­sa fever vac­cines af­ter ear­ly tri­als dis­ap­point

3 years ago
R&D

Take­da touts pos­i­tive first-line leukemia re­sults — but is­n't quite ready to re­veal the hard da­ta

3 years ago
Pharma
FDA+

Lil­ly wins FDA ap­proval for sec­ond in­ter­change­able in­sulin biosim­i­lar

3 years ago
Pharma
FDA+

Phar­ma foe Bernie Sanders to take over lead­er­ship of Sen­ate health com­mit­tee

3 years ago
Pharma
Law

Van­da ap­peals to FDA again, in­sist­ing on sN­DA hear­ing in lat­est wrin­kle in jet lag drug saga

3 years ago
Pharma

Pre­dic­tive mar­ket­ing moves in­to elec­tron­ic health records, tar­get­ing doc­tors at ex­act points of care

3 years ago
Pharma
Marketing

GSK once again tops drug ac­ces­si­bil­i­ty rank­ing, with J&J and As­traZeneca close be­hind

3 years ago
Pharma
Marketing

FDA lead­ers Califf and Paz­dur dish on ac­cel­er­at­ed ap­proval re­forms, sin­gle-coun­try tri­als and an emp­ty White Oak

3 years ago
FDA+

Ra­dioiso­tope com­pa­ny moves for­ward with CD­MO plans, break­ing ground on new man­u­fac­tur­ing site in Wis­con­sin

3 years ago
Pharma
Manufacturing

Man­u­fac­tur­ing roundup: Cel­l­Vax part­ners up with Ther­a­gent for PhII tri­al; Ox­ford Bio­med­ica sells fa­cil­i­ty for $70M+

3 years ago
Manufacturing

Ed­i­tas halts lead CRISPR pro­gram af­ter ef­fi­ca­cy da­ta un­der­whelm

3 years ago
R&D
Cell/Gene Tx

As bi­va­lent boost­er up­take crawls, Pfiz­er and BioN­Tech start ear­ly-stage pan-vari­ant tri­al

3 years ago
Coronavirus

Cure­Vac puts lead on­col­o­gy can­di­date on back burn­er and will on­ly move it for­ward in com­bi­na­tion ther­a­pies

3 years ago
R&D
First page Previous page 426427428429430431432 Next page Last page
A service from the Financial Times